The groundbreaking therapy of tirzepatide peptide represents a exciting development in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP https://tirzepatidepeptide306260.ja-blog.com/42334514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment